Literature DB >> 17523274

Can procalcitonin help us in timing of re-intervention in septic patients after multiple trauma or major surgery?

Petr Svoboda1, Iona Kantorová, Peter Scheer, Jana Radvanova, Martin Radvan.   

Abstract

BACKGROUND/AIMS: In surgical sepsis, the rapid identification of source of infection at an early stage after surgery or serious trauma is crucial for favorable outcome. The discrimination between local and generalized infection is critical for correct treatment.
METHODOLOGY: In a randomized, controlled, single-centre study we investigated 72 patients with severe sepsis after major abdominal surgery or surgery for multiple trauma. Patients were divided in 2 groups: in the first group (PCT, n=38), more important role in the treatment decision was given to PCT level (severe sepsis with PCT >2 ng/mL signalled bacteremia and pushed us to change antibiotics and intravascular devices, severe sepsis with PCT < or =2 ng/mL prompted use of ultrasonography and/or CT, followed by repeated surgery in patients with localized infection). The control group (CON, n=34) was treated by standard evaluation of all parameters by consultant surgeon. We investigated 28-day all-cause mortality, sepsis-related complications, the duration of stay in the intensive care unit, and ventilated days.
RESULTS: The hospital mortality was in PCT group 26% and 38% in control group (p = 0.28). Average SOFA score was 7.9 +/- 2.8 in PCT group vs. 9.3 +/- 3.3 (p = 0.06). The decline of ICU days (16.1 +/- 6.9 vs. 19.4 +/- 8.9; p = 0.09) and ventilated days (10.3 +/- 7.8 vs. 13.9 +/- 9.4; p = 0.08) in PCT group was observed, but the difference was not significant.
CONCLUSIONS: We observed a clear tendency to decrease extent of multiple organ dysfunction syndrome in patients, in which therapeutic decision was made earlier using procalcitonin as an additional marker separating local infection from generalized one.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17523274

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  29 in total

Review 1.  An ESICM systematic review and meta-analysis of procalcitonin-guided antibiotic therapy algorithms in adult critically ill patients.

Authors:  Dimitrios K Matthaiou; Georgia Ntani; Marina Kontogiorgi; Garyfallia Poulakou; Apostolos Armaganidis; George Dimopoulos
Journal:  Intensive Care Med       Date:  2012-04-27       Impact factor: 17.440

Review 2.  Effect of procalcitonin-guided treatment in patients with infections: a systematic review and meta-analysis.

Authors:  H Tang; T Huang; J Jing; H Shen; W Cui
Journal:  Infection       Date:  2009-10-13       Impact factor: 3.553

Review 3.  [Reducing mortality in adults with sepsis, severe sepsis, or septic shock: effectiveness and safety of procalcitonin].

Authors:  Laila Schneidewind
Journal:  Urologe A       Date:  2021-03-29       Impact factor: 0.639

Review 4.  Procalcitonin-guided antibiotic treatment in critically ill patients.

Authors:  Andreas Hohn; Bernhard Heising; Jan-Karl Schütte; Olaf Schroeder; Stefan Schröder
Journal:  Langenbecks Arch Surg       Date:  2016-06-10       Impact factor: 3.445

Review 5.  Effectiveness and safety of procalcitonin evaluation for reducing mortality in adults with sepsis, severe sepsis or septic shock.

Authors:  Brenda Ng Andriolo; Regis B Andriolo; Reinaldo Salomão; Álvaro N Atallah
Journal:  Cochrane Database Syst Rev       Date:  2017-01-18

Review 6.  AME evidence series 001-The Society for Translational Medicine: clinical practice guidelines for diagnosis and early identification of sepsis in the hospital.

Authors:  Zhongheng Zhang; Nathan J Smischney; Haibo Zhang; Sven Van Poucke; Panagiotis Tsirigotis; Jordi Rello; Patrick M Honore; Win Sen Kuan; Juliet June Ray; Jiancang Zhou; You Shang; Yuetian Yu; Christian Jung; Chiara Robba; Fabio Silvio Taccone; Pietro Caironi; David Grimaldi; Stefan Hofer; George Dimopoulos; Marc Leone; Sang-Bum Hong; Mabrouk Bahloul; Laurent Argaud; Won Young Kim; Herbert D Spapen; Jose Rodolfo Rocco
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

Review 7.  [Procalcitonin-based algorithm. Management of antibiotic therapy in critically ill patients].

Authors:  M Hochreiter; S Schroeder
Journal:  Anaesthesist       Date:  2011-07       Impact factor: 1.041

8.  A randomized trial to compare procalcitonin and C-reactive protein in assessing severity of sepsis and in guiding antibacterial therapy in Egyptian critically ill patients.

Authors:  Walid A Ali; Naglaa S Bazan; Ahmed A Elberry; Raghda R S Hussein
Journal:  Ir J Med Sci       Date:  2021-01-14       Impact factor: 1.568

9.  New approaches to sepsis: molecular diagnostics and biomarkers.

Authors:  Konrad Reinhart; Michael Bauer; Niels C Riedemann; Christiane S Hartog
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

10.  Early serum procalcitonin, interleukin-6, and 24-hour lactate clearance: useful indicators of septic infections in severely traumatized patients.

Authors:  Adrian Billeter; Matthias Turina; Burkhardt Seifert; Ladislav Mica; Reto Stocker; Marius Keel
Journal:  World J Surg       Date:  2009-03       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.